ID

12899

Beschreibung

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00136422

Link

https://clinicaltrials.gov/show/NCT00136422

Stichworte

Versionen (1)
  1. 05.01.16 05.01.16 -
Hochgeladen am

5. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Acute Myelogenous Leukemia NCT00136422

Englisch

Eligibility Acute Myelogenous Leukemia NCT00136422

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have pathologically documented myelodysplasia or acute myelogenous leukemia.
Beschreibung

myelodysplastic syndrome, myeloid leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2]
C0023467
the patients with myelodysplasia must also have: french-american-british (fab) subtype refractory anemia with excess blasts (raeb) or refractory anemia with excess blasts in transformation (raeb-t), or normal or hypercellular bone marrow.
Beschreibung

inclusion myelodysplastic syndrome

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3463824
UMLS CUI [1,2]
C1512693
UMLS CUI [2]
C2984084
UMLS CUI [3]
C0005953
the patients with acute myelogenous leukemia must also: not be candidates for myelosuppressive chemotherapy due to age or comorbid disease, or have relapsed acute myelogenous leukemia or be refractory to standard therapy and not likely to require cytoreductive therapy within 60 days
Beschreibung

inclusion acute myelogenous leukemia

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0023467
UMLS CUI [1,2]
C1512693
UMLS CUI [2]
C0392920
UMLS CUI [3]
C0277556
UMLS CUI [4]
C0205269
eastern cooperative oncology group (ecog) performance status 0 or 1.
Beschreibung

ecog performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
estimated life expectancy of 6 months or greater.
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
age at least 18 years.
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
greater than 4 weeks from any chemotherapy, radiotherapy, immunotherapy, or systemic glucocorticoid therapy (non-glucocorticoid hormonal therapy allowed).
Beschreibung

therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
greater than 2 months following bone marrow or peripheral blood stem cell transplantation or treatment with donor lymphocyte infusion (dli).
Beschreibung

stem cell transplant, dli

Datentyp

boolean

Alias
UMLS CUI [1]
C1504389
UMLS CUI [2]
C1512034
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled active infection.
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0517627
pregnancy or nursing mothers.
Beschreibung

pregnancy, breastfeeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
previous participation in an adenovirus based trial.
Beschreibung

study subject participation status

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
the patients with myelodysplasia who have either: fab subtype refractory anemia (ra), refractory anemia with ringed sideroblasts (rars), chronic myelomonocytic leukemia (cmml), or the presence of hypocellular bone marrow.
Beschreibung

exclusion myelodysplastic syndrome

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C3463824
UMLS CUI [2]
C2984084
UMLS CUI [3]
C0005953
chemotherapy, radiotherapy, immunotherapy, or systemic steroid therapy within the last 4 weeks.
Beschreibung

therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0021083
UMLS CUI [4]
C0038317
active central nervous system (cns) disease.
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0007682
evidence of infection with the human immunodeficiency virus.
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0019682
active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely.
Beschreibung

comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0004936
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Acute Myelogenous Leukemia NCT00136422

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
myelodysplastic syndrome, myeloid leukemia
Item
patients must have pathologically documented myelodysplasia or acute myelogenous leukemia.
boolean
C3463824 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
inclusion myelodysplastic syndrome
Item
the patients with myelodysplasia must also have: french-american-british (fab) subtype refractory anemia with excess blasts (raeb) or refractory anemia with excess blasts in transformation (raeb-t), or normal or hypercellular bone marrow.
boolean
C3463824 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C2984084 (UMLS CUI [2])
C0005953 (UMLS CUI [3])
inclusion acute myelogenous leukemia
Item
the patients with acute myelogenous leukemia must also: not be candidates for myelosuppressive chemotherapy due to age or comorbid disease, or have relapsed acute myelogenous leukemia or be refractory to standard therapy and not likely to require cytoreductive therapy within 60 days
boolean
C0023467 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C0205269 (UMLS CUI [4])
ecog performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1.
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
estimated life expectancy of 6 months or greater.
boolean
C0023671 (UMLS CUI [1])
age
Item
age at least 18 years.
boolean
C0001779 (UMLS CUI [1])
therapy
Item
greater than 4 weeks from any chemotherapy, radiotherapy, immunotherapy, or systemic glucocorticoid therapy (non-glucocorticoid hormonal therapy allowed).
boolean
C0087111 (UMLS CUI [1])
stem cell transplant, dli
Item
greater than 2 months following bone marrow or peripheral blood stem cell transplantation or treatment with donor lymphocyte infusion (dli).
boolean
C1504389 (UMLS CUI [1])
C1512034 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
comorbidity
Item
uncontrolled active infection.
boolean
C0009488 (UMLS CUI [1,1])
C0517627 (UMLS CUI [1,2])
pregnancy, breastfeeding
Item
pregnancy or nursing mothers.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
study subject participation status
Item
previous participation in an adenovirus based trial.
boolean
C2348568 (UMLS CUI [1])
exclusion myelodysplastic syndrome
Item
the patients with myelodysplasia who have either: fab subtype refractory anemia (ra), refractory anemia with ringed sideroblasts (rars), chronic myelomonocytic leukemia (cmml), or the presence of hypocellular bone marrow.
boolean
C0680251 (UMLS CUI [1,1])
C3463824 (UMLS CUI [1,2])
C2984084 (UMLS CUI [2])
C0005953 (UMLS CUI [3])
therapy
Item
chemotherapy, radiotherapy, immunotherapy, or systemic steroid therapy within the last 4 weeks.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C0038317 (UMLS CUI [4])
comorbidity
Item
active central nervous system (cns) disease.
boolean
C0009488 (UMLS CUI [1,1])
C0007682 (UMLS CUI [1,2])
comorbidity
Item
evidence of infection with the human immunodeficiency virus.
boolean
C0009488 (UMLS CUI [1,1])
C0019682 (UMLS CUI [1,2])
comorbidity
Item
active psychiatric or mental illness making informed consent or careful clinical follow-up unlikely.
boolean
C0009488 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video